The store will not work correctly when cookies are disabled.
N-(2,6-dichlorophenyl)-4-methoxy-N-methylquinolin-6-amine
ID: ALA4575148
PubChem CID: 121005807
Max Phase: Preclinical
Molecular Formula: C17H14Cl2N2O
Molecular Weight: 333.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccnc2ccc(N(C)c3c(Cl)cccc3Cl)cc12
Standard InChI: InChI=1S/C17H14Cl2N2O/c1-21(17-13(18)4-3-5-14(17)19)11-6-7-15-12(10-11)16(22-2)8-9-20-15/h3-10H,1-2H3
Standard InChI Key: IQXIXPLQQDFASE-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
11.9282 -9.8239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6421 -9.4269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6518 -8.6098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9518 -8.1898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2380 -8.5869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5339 -8.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8200 -8.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8103 -9.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5103 -9.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2241 -9.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1200 -8.1481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4062 -8.5452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9616 -7.3728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6754 -6.9757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1298 -7.3311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8436 -6.9340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8575 -6.1169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1575 -5.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4437 -6.0940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4298 -6.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7160 -7.3123 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.5477 -7.3540 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
7 11 1 0
11 12 1 0
13 14 1 0
4 13 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
20 21 1 0
16 22 1 0
11 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.22 | Molecular Weight (Monoisotopic): 332.0483 | AlogP: 5.32 | #Rotatable Bonds: 3 |
Polar Surface Area: 25.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 6.29 | CX LogP: 4.84 | CX LogD: 4.81 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: -0.89 |
References
1. Scheufler C, Möbitz H, Gaul C, Ragot C, Be C, Fernández C, Beyer KS, Tiedt R, Stauffer F.. (2016) Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket., 7 (8): [PMID:27563394] [10.1021/acsmedchemlett.6b00168] |